Showing 1 - 20 results of 21 for search 'Xuezhi HAO', query time: 0.05s
Refine Results
-
1
-
2
Utility of NSE, ProGRP and LDH in Diagnosis and Treatment in Patients with Small Cell Lung Cancer by Yan PENG, Yan WANG, Junling LI, Xuezhi HAO, Xingsheng HU
Published 2016-09-01
Article -
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Adjuvant chemotherapy in patients with recurrence after completely resected stage IB lung adenocarcinoma: Propensity‐matched analysis in a cohort of 147 recurrences by Fei Xu, Heng‐chi Chen, Haiyan Xu, Junling Li, Xuezhi Hao, Puyuan Xing, Jianming Ying, Yan Wang
Published 2022-11-01
Article -
11
-
12
A Retrospective Study of the Efficacy and Toxicity of Irinotecan in Combination with Nedaplatin versus Irinotecan in Combination with Cisplatin as Salvage Treatment in Refractory o... by Shufei YU, Yan WANG, Xingsheng HU, Hongyu WANG, Xuezhi HAO, Jianping XU, Junling LI, Xiangru ZHANG, Yuankai SHI
Published 2013-09-01
Article -
13
RETRACTED ARTICLE: Long noncoding RNA HEIH depletion depresses esophageal carcinoma cell progression by upregulating microRNA-185 and downregulating KLK5 by Bing Wang, Xuezhi Hao, Xingkai Li, Yicheng Liang, Fang Li, Kun Yang, Hengqi Chen, Fang Lv, Yushun Gao
Published 2020-11-01
Article -
14
-
15
-
16
First‐line immunotherapy or angiogenesis inhibitor combined with chemotherapy for advanced non‐small cell lung cancer with EGFR exon 20 insertions: Real‐world evidence from China... by Guangjian Yang, Yaning Yang, Runze Liu, Weihua Li, Haiyan Xu, Xuezhi Hao, Junling Li, Shuyang Zhang, Fei Xu, Siyu Lei, Yan Wang
Published 2023-01-01
Article -
17
Effectiveness of neoadjuvant immunochemotherapy compared to neoadjuvant chemotherapy in non-small cell lung cancer patients: Real-world data of a retrospective, dual-center study by Kailun Fei, Kailun Fei, Gang Guo, Gang Guo, Jie Wang, Jie Wang, Zhijie Wang, Zhijie Wang, Yan Wang, Yan Wang, Xuezhi Hao, Xuezhi Hao, Jia Zhong, Jia Zhong, Qinxiang Guo, Wei Guo, Wenzhong Su, Likun Zan, Jiaxi Xu, Fengwei Tan, Xiaofei Zhuang, Xiaofei Zhuang, Jianchun Duan, Jianchun Duan, Jianchun Duan
Published 2023-03-01
Article -
18
Treatment patterns and outcomes of immunotherapy in extensive‐stage small‐cell lung cancer based on real‐world practice by Yaning Yang, Xin Ai, Haiyan Xu, Guangjian Yang, Lu Yang, Xuezhi Hao, Ke Yang, Yuling Mi, Guizhen Wang, Shuyang Zhang, Siyu Lei, Yan Wang
Published 2022-12-01
Article -
19
Efficacy of Chemotherapy after EGFR-TKIs Resistance in 191 Patients with Unknow EGFR Gene Mutation in Advanced Lung Adenocarcinoma by Ping HE, Yan WANG, Sheng YANG, Shufei YU, Ziping WANG, Junling LI, Bin WANG, Xuezhi HAO, Hongyu WANG, Xingsheng HU, Xiangru ZHANG, Yuankai SHI
Published 2013-10-01
Article -
20
Pyrotinib combined with apatinib for targeting metastatic non-small cell lung cancer with HER2 alterations: a prospective, open-label, single-arm phase 2 study (PATHER2) by Guangjian Yang, Haiyan Xu, Yaning Yang, Shuyang Zhang, Fei Xu, Xuezhi Hao, Junling Li, Puyuan Xing, Xingsheng Hu, Yutao Liu, Lin Wang, Lin Lin, Zhijie Wang, Jianchun Duan, Jie Wang, Yan Wang
Published 2022-08-01
Article